Jefferies & Co Initiates Coverage on Millipore (MIL) with a Buy
More News related to MIL
- Millipore (MIL) Acquires Remaining Ownership of Joint-Venture in India
- Millipore Acquires Remaining Ownership of its Joint-Venture in India
- Millipore Launches First Automated Cell Counter that Fits Into the Palm of the Hand
- Millipore Corporation named Corporate Citizen of the Year
- EnerNOC Honored as New England Clean Energy Council's Breakout Company of the Year
Jefferies & Co initiates coverage on Millipore (NYSE: MIL) with a Buy rating. Price target $85.
To see more analyst ratings on MIL Click Here.
Millipore Corporation, a life science company, provides technologies, tools, and services for bioscience research and biopharmaceutical manufacturing industry in the Americas, Europe, and the Asia Pacific.
Related Categories
New CoverageStocks Mentioned
-0.42Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
